Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.
J Pak Med Assoc
; 70(Suppl 3)(5): S48-S51, 2020 May.
Article
in English
| MEDLINE | ID: covidwho-609380
ABSTRACT
COVID-19 poses a great challenge to clinical and diagnostic services around the world. The need of biosafety practices can never be emphasised more than under current circumstances. The four pillars of biosafety namely, leadership, standard operating procedures, personal protective equipment (PPE) and engineering controls must be employed for effective and safe practices in the clinical setting in general and laboratory settings in particular. Risk assessment must be carried out before meeting up the diagnostic challenge for COVID-19 and essential biorisk management measures are required to be taken. In our resource-poor settings, we need to adapt safe but cost-effective and improvised solutions to ensure safe handling of clinical samples from COVID-19 patients in the laboratories. The correct use of PPE and their suitable alternatives are available for selection and use. Disinfection of the lab areas and safe disposal of the clinical samples from such patients is also of paramount importance.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Containment of Biohazards
/
Clinical Laboratory Techniques
/
Pandemics
/
Betacoronavirus
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Pak Med Assoc
Year:
2020
Document Type:
Article
Affiliation country:
JPMA.10
Similar
MEDLINE
...
LILACS
LIS